6-42173588-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001384910.1(GUCA1A):c.-26A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0264 in 1,592,506 control chromosomes in the GnomAD database, including 8,388 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 4430 hom., cov: 33)
Exomes 𝑓: 0.015 ( 3958 hom. )
Consequence
GUCA1A
NM_001384910.1 5_prime_UTR
NM_001384910.1 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.226
Genes affected
GUCA1A (HGNC:4678): (guanylate cyclase activator 1A) This gene encodes an enzyme that plays a role in the recovery of retinal photoreceptors from photobleaching. This enzyme promotes the activity of retinal guanylyl cyclase-1 (GC1) at low calcium concentrations and inhibits GC1 at high calcium concentrations. Mutations in this gene can cause cone dystrophy 3 and code-rod dystrophy 14. provided by RefSeq, Jul 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 6-42173588-A-G is Benign according to our data. Variant chr6-42173588-A-G is described in ClinVar as [Benign]. Clinvar id is 356691.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.45 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GUCA1A | NM_001384910.1 | c.-26A>G | 5_prime_UTR_variant | 1/4 | ENST00000372958.2 | NP_001371839.1 | ||
GUCA1ANB-GUCA1A | NM_001319061.2 | c.-26A>G | 5_prime_UTR_variant | 3/6 | NP_001305990.1 | |||
GUCA1ANB-GUCA1A | NM_000409.5 | c.-26A>G | 5_prime_UTR_variant | 3/6 | NP_000400.2 | |||
GUCA1ANB-GUCA1A | NM_001319062.2 | c.-26A>G | 5_prime_UTR_variant | 2/5 | NP_001305991.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GUCA1A | ENST00000372958.2 | c.-26A>G | 5_prime_UTR_variant | 1/4 | 1 | NM_001384910.1 | ENSP00000362049 | P1 |
Frequencies
GnomAD3 genomes AF: 0.133 AC: 20274AN: 152134Hom.: 4410 Cov.: 33
GnomAD3 genomes
AF:
AC:
20274
AN:
152134
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0361 AC: 9069AN: 250898Hom.: 1736 AF XY: 0.0269 AC XY: 3646AN XY: 135652
GnomAD3 exomes
AF:
AC:
9069
AN:
250898
Hom.:
AF XY:
AC XY:
3646
AN XY:
135652
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0151 AC: 21749AN: 1440254Hom.: 3958 Cov.: 28 AF XY: 0.0132 AC XY: 9469AN XY: 717862
GnomAD4 exome
AF:
AC:
21749
AN:
1440254
Hom.:
Cov.:
28
AF XY:
AC XY:
9469
AN XY:
717862
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.134 AC: 20341AN: 152252Hom.: 4430 Cov.: 33 AF XY: 0.129 AC XY: 9618AN XY: 74466
GnomAD4 genome
AF:
AC:
20341
AN:
152252
Hom.:
Cov.:
33
AF XY:
AC XY:
9618
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
115
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cone dystrophy 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at